|
Delayed
Nasdaq Stockholm
17:00:00 20/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 8.860 SEK | -1.45% |
|
-1.45% | -34.37% |
| 08-13 | Vivesto narrowed its loss in the second quarter, CEO says: we are staying on plan | FW |
| 08-13 | Vivesto AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 98.09M 10.35M 8.86M 8.27M 7.59M 14.26M 990M 14.54M 38.24M 496M 38.86M 38.02M 1.64B | P/E 2026 * |
-2.94x | P/E 2027 * | -2.45x |
|---|---|---|---|---|---|
| Enterprise Value | 90.09M 9.51M 8.14M 7.59M 6.97M 13.09M 910M 13.35M 35.12M 456M 35.7M 34.92M 1.51B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
52.67% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Vivesto AB
| 1 day | -1.45% | ||
| 1 week | -1.45% | ||
| Current month | +5.73% | ||
| 1 month | +0.68% | ||
| 3 months | +5.48% | ||
| 6 months | +2.19% | ||
| Current year | -34.37% |
| 1 week | 8.5 |  | 9.03 |
| 1 month | 8.26 | | 9.14 |
| Current year | 7 | | 19.5 |
| 1 year | 7 | | 27.3 |
| 3 years | 7 | | 90.6 |
| 5 years | 7 | | 302.9 |
| 10 years | 7 | | 1,670 |
| Manager | Title | Age | Since |
|---|---|---|---|
Erik Kinnman
CEO | Chief Executive Officer | 68 | 22/01/2023 |
Björn Svanström
DFI | Director of Finance/CFO | 55 | 30/06/2026 |
| Chief Tech/Sci/R&D Officer | 39 | 31/12/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 46 | 24/05/2022 | |
Hege Hellstrom
BRD | Director/Board Member | 61 | 25/09/2019 |
Pål Ryfors
BRD | Director/Board Member | 43 | 24/05/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 25/03/22 | Buy | Chief Executive Officer | 12,200 | 0.0027% | ||
| 24/03/22 | Others | Chairman | 120,000 | 0.0268% | ||
| 20/12/21 | Free | Chief Executive Officer | 2,250,000 | 0.5018% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.45% | -1.45% | -63.24% | -64.13% | 10.35M | |
| -2.81% | +2.93% | +76.40% | +127.73% | 1,109B | |
| -2.21% | +2.02% | +49.50% | +55.01% | 644B | |
| -1.56% | +4.39% | +25.19% | +74.39% | 463B | |
| -1.05% | +2.62% | +41.69% | +45.78% | 371B | |
| -0.59% | +2.10% | +23.43% | +41.34% | 301B | |
| -0.82% | +3.25% | +0.94% | +13.42% | 256B | |
| -1.95% | +3.80% | +46.31% | +65.66% | 234B | |
| +0.76% | -0.70% | -14.31% | -52.66% | 205B | |
| -2.82% | +3.84% | +20.81% | +89.04% | 178B | |
| Average | -1.48% | +2.56% | +20.67% | +39.56% | 376.11B | |
| Weighted average by Cap. | -1.84% | +3.26% | +43.26% | +70.42% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -31M -3.27M -2.8M -2.61M -2.4M -4.51M -313M -4.59M -12.08M -157M -12.28M -12.02M -519M | -40M -4.22M -3.61M -3.37M -3.09M -5.81M -404M -5.93M -15.59M -202M -15.85M -15.5M -670M |
| Net Debt | -8M -844K -723K -674K -619K -1.16M -80.77M -1.19M -3.12M -40.48M -3.17M -3.1M -134M | -17M -1.79M -1.54M -1.43M -1.31M -2.47M -172M -2.52M -6.63M -86.02M -6.74M -6.59M -285M |
Employees
4
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/08/26 | SEK 8.860 | -1.45% | 6,741 |
| 19/08/26 | SEK 8.990 | -0.22% | 13,445 |
| 18/08/26 | SEK 9.010 | +3.33% | 43,456 |
| 17/08/26 | SEK 8.720 | -2.90% | 10,595 |
| 14/08/26 | SEK 8.980 | -0.11% | 1,575 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- VIVE Stock
Select your edition
All financial news and data tailored to specific country editions
